Media

Support Of Industry Underscores Pro-Business Commitment
Commercialization of cleaner, safer consumer products through innovative industrial biotechnology processes will be the focus of breakout sessions at the...

Press Releases

Dec 7 2000
New HealthFest 2001 Event and “Partnering for Life” ThemeExpected to Attract 12,000 WASHINGTON, D.C. (December 7, 2000) – San Diego will host the Biotechnology...
Nov 21 2000
WASHINGTON, D.C. (November 21, 2000) -- The Biotechnology Industry Organization (BIO) achieved significant legislative objectives during the 106th Congress...
Nov 17 2000
WASHINGTON (November 17, 2000)-The Biotechnology Industry Organization (BIO) today named Matthew D. Lyons director of government relations for food and...
Oct 19 2000
WASHINGTON (October 19, 2000)-The Environmental Protection Agency (EPA) reaffirmed Thursday that a review of all available scientific information indicates...
Oct 19 2000
At the strong urging of the Environmental Protection Agency, Aventis is announcing today that they are canceling the registration of StarLink corn. This means...
Oct 18 2000
WASHINGTON, D.C. (October 18, 2000) - Biotechnology Industry Organization (BIO) President, Carl B. Feldbaum, today issued the following statement on the drug...
Oct 16 2000
WASHINGTON, D.C. (October 16, 2000) -- The Biotechnology Industry Organization (BIO) has asked the U.S. Court of Appeals for the Federal Circuit for a...
Oct 5 2000
WASHINGTON, D.C. (October 5, 2000) - A report released today documents that biotechnology drugs already on the market have a major impact on eight...
Oct 4 2000
WASHINGTON, D.C. (October 4, 2000) The Biotechnology Industry Organization (BIO) today urged President Clinton to sign the American Competitiveness in the 21st...


Biotechnology News

September 20, 2014

MONT-TREMBLANT, Quebec--(BUSINESS WIRE)--FibroGen, Inc. (FibroGen) announced today the presentation of the full data set from a clinical study of patients with idiopathic...

September 19, 2014

LOS ANGELES--(BUSINESS WIRE)--Contact Glancy Binkow & Goldberg LLP if you purchased PDL BioPharma, Inc. securities between November 6, 2013 and September 16, 2014.

September 19, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a...

September 19, 2014

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research will present at BioCentury’s 21st Annual NewsMakers in the Biotech Industry conference on September 26, 2014 at 10:30...

September 19, 2014

PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)--Regulatory News: Onxeo SA (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ OMX Copenhagen - ONXEO), an innovative...